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gonorrhea and describe a newly developed female mouse model 
of gonorrhea chlamydia coinfection for pathogenesis studies and 
developing products against pelvic inflammatory disease (PID).
ANIMAL MODELING OF GONOCOCCAL INFECTIONS
In the 1970s and 1980s, much effort was invested toward develop-
ing animal models of Gc infection. Genital tract infection was only 
successful in chimpanzees (Arko, 1989), which are no longer used 
for gonorrhea research due to their enormous cost and limited 
availability. Fortunately, a clue as to the role of the murine estrous 
cycle in inhibiting Gc colonization came from the discovery that 
female mice can be colonized when challenged during the proestrus 
stage of the estrous cycle. Gc is cleared upon transition into the post-
ovulatory stages, and because the estrous cycle lasts only 4–6 days, 
Gc is recovered for only a few days (Streeter and Corbeil, 1981; 
Braude, 1982; Johnson et al., 1989). In 1990, Taylor-Robinson et al. 
(1990) described the use of 17β-estradiol to promote long-term 
colonization of germ-free BALB/c mice with Gc. Ten years later 
we confirmed Taylor-Robinson’s report and developed a protocol 
in which long-term Gc infection can be established in estradiol-
treated BALB/c mice given antibiotics to suppress the overgrowth 
of commensal flora that occurs under the influence of estrogen 
(Jerse, 1999; Song et al., 2008; Figure 1A).
The susceptibility of rodents to human genital tract pathogens is 
often linked to the estrous cycle and the use of steroid hormones to 
promote susceptiblity to Gc is consistent with other mouse models 
of sexually transmitted infections (STIs; Furr et al., 1989; Zeitlin 
INTRODUCTION
The success of Neisseria gonorrhoeae (Gc) as a pathogen stems 
from the evolution of several sophisticated adaptation mecha-
nisms that maintain its sole reservoir on the mucosae of infected 
humans. Some of these mechanisms are sex-specific and in the 
case of female infection, their evolution appears to be shaped by 
hormonal influences. Gc is also a genetically flexible pathogen that 
utilizes phase and antigenic variation to evade or capitalize upon 
host factors (Simms and Jerse, 2005) and the immunobiology of 
gonorrhea is both fascinating and puzzling due to the persistence 
of this organism during intense inflammation and the efficiency 
by which gonorrhea is transmitted to naïve and previously infected 
individuals (Sparling, 1999). Continued studies of the pathogenesis 
of this organism is therefore a rich field of investigation that can 
benefit from animal modeling to allow testing of hypotheses in 
the context of an intact host. Translational research is also needed 
to meet the pressing need for new prophylactic and therapeutic 
strategies against gonorrhea (Tapsall, 2009; Lewis, 2010).
Historically, animal modeling of Gc infections has been chal-
lenged by several host restrictions. However, the use of estradiol-
treated mice as surrogate hosts for Gc has partially fulfilled the need 
for an animal model of Gc genital tract infection. Here we describe 
the characteristics and limitations of experimental murine infec-
tion, the potential of transgenic mice to improve the mouse system, 
and information gained thus far on Gc adaptation to the female 
genital tract using this model. We also briefly discuss the use of 
this model in developing vaccines and vaginal microbicides against 
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et al., 2001; Darville et al., 2003; McGowin et al., 2009) and vaginal 
candidiasis (Fidel et al., 2000). The reason 17β-estradiol promotes 
susceptibility to Gc in mice is not known. The histology and physi-
ology of the genital tracts of estradiol-treated mice mimic the most 
hospitable stages of the estrous cycle for Gc and estradiol suppresses 
the natural influx of polymorphonuclear leukocytes (PMNs) 
that occurs after ovulation. Estradiol is also likely to dampen the 
inflammatory response based on its immunosuppressive effect on 
cytokine production (Straub, 2007) or may alter the concentra-
tions of innate receptors and effectors known to be influenced by 
reproductive hormones (Li et al., 2002; Yao et al., 2007).
CHARACTERISTICS OF MURINE GENITAL TRACT INFECTION
LOCALIzATION OF INFECTION AND COLONIzATION KINETICS
Using the protocols we have described, Gc is recovered from the 
lower genital tracts of estradiol-treated BALB/c mice for an average 
of 12 days in a 14-day period and as long as 40 days when slow-
release estradiol pellets are used, and for an average of 10 days when 
three injections of water-soluble estradiol are given (Jerse, 1999; 
Jerse et al., 2002; Song et al., 2008). Gc is localized in the vaginal 
lumen and within vaginal and cervical tissue, including the lamina 
propria (Song et al., 2008). Endometrial cultures are positive in 
17–20% of mice (Jerse, 1999), a rate that is similar to that reported 
for ascended cervical infections in women (Hook and Holmes, 
1985). This rate may be dose-dependent and actually higher based 
on the detection of Gc in endometrial tissue by confocal fluorescent 
microscopy (Imarai et al., 2008). Mouse-passaged strains are not 
required for murine infection and in early experiments, did not 
show an enhanced capacity to colonize (Jerse, 1999).
Following inoculation of BALB/c mice with 106 CFU of Gc 
strains FA1090 or MS11, the average number of Gc recovered from 
a single vaginal swab ranges from 101 to 106 CFU with most cultures 
yielding 103–105 CFU (Figure 1B; Jerse, 1999; Jerse et al., 2002; 
Soler-Garcia and Jerse, 2007; Song et al., 2008). Periods of dramati-
cally reduced recovery or negative cultures are observed followed by 
a marked increase in recovery in 60–80% of BALB/c mice inocu-
lated with Gc strains FA1090 or 1291 (Jerse, 1999; Simms and Jerse, 
2006; and O. Jones-Nelson and Jerse, unpublished observations). 
We refer to these periods of reduced recovery as culture negative 
windows or the mid-phase of infection. (Jerse, 1999; Simms and 
Jerse, 2006) and have evidence that this pattern is hormonally regu-
lated (Cole et al., 2010). It is critical that researchers who use this 
model be aware of fluctuations in colonization levels, particularly 
when measuring the effect of a particular host response on clear-
ance or testing the efficacy of vaccines or therapeutic products. We 
obtain negative cultures for five consecutive days from mice that 
appear to have resolved infection before concluding infection has 
cleared. It is also important to understand that the estrous cycle 
will resume as the effects of the estradiol wear off, and mice will 
re-gain their natural resistance to infection upon transition into 
the luteul phase (Figure 1B). Additional doses of estradiol can be 
administered to prolong infection further.
HOST RESpONSE TO INFECTION
Gonorrhea in women is characterized by a mucopurulent cervical 
discharge with numerous PMNs or it can be asymptomatic with 
over 50% of women reporting no symptoms (Hook and Holmes, 
Figure 1 | Schematic of mouse infection protocol and characteristics of 
infection. (A) In our laboratory, mice are treated with 17β-estradiol to promote 
Gc infection by implantation of a slow-release pellet under their skin (Jerse, 
1999; not shown) or subcutaneous administration of water-soluble estradiol 
(estradiolws; 0.5 mg) on days −2, 0, and 2 (Song et al., 2008). The benefit of 
using estradiolws is that serum estradiol concentrations return to physiological 
levels within 24 h after administration, and in our treatment protocol, Gc is not 
exposed to abnormal levels by day 3 of infection as shown. The dotted line 
corresponds to estradiol levels in normal proestrus stage mice (Dalal et al., 
2001) Mice are inoculated with bacteria on day 0. Not shown is the antibiotic 
treatment regimen, which has been adjusted over time due to changes in 
breeders and husbandry practices. Currently, streptomycin sulfate (Sm; 
2.4 mg) and vancomycin hydrochloride (0.4 mg) are administered via 
intraperitoneal (i.p.) inoculation twice daily until day 2 of the infection period. 
Drinking water with trimethoprim sulfate (0.04 g/100 ml water) is used over 
the course of the experiment, with Sm (0.5 g/100 ml water) added on day 2 of 
the infection period. (B) An example of the average number of CFU recovered 
from a single vaginal swab suspended in 100 μl of PBS (left axis) and percent 
of PMNs in stained vaginal smears (right axis) is shown. Mice (n = 6) in this 
experiment were inoculated with 106 CFU of strain FA1090. In published 
(Packiam et al., 2010) and unpublished data from our laboratory, increased 
levels of proinflammatory cytokines and chemokines are detected on day 5 of 
infection as shown, which corresponds to the influx of PMNs in infected mice. 
Asterisks denote time points at which the percentage of PMNs in infected 
mice (dashed lines, solid squares) was significantly higher than that in mice 
given PBS (dashed lines, open squares). Increased PMNs were observed in 
control mice on days 9 and 10, which is due to the effects of the estradiol 
wearing off and the resumption of the estrous cycle. Mice were colonized for 
an average of 9.9 days in this 12-day experiment. This figure was constructed 
with combined data reported in (Song et al., 2008; Packiam et al., 2010).
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mice that were previously infected with the same strain compared 
to naïve age-matched, estradiol-treated control mice (Song et al., 
2008). Imarai et al. (2008) investigated the basis for the lack of a 
humoral response to Gc using the mouse system. Gc were detected 
in endometrial tissue from estradiol-treated BALB/c mice for as 
long as 22 days and importantly, significantly higher numbers of 
TGF-β1+ CD4+ T cells and a subset of CD4+ CD25+ Foxp3+ T cells 
were detected in the regional lymph nodes of infected mice com-
pared to control mice. Increased infiltration of TGF-β1+ CD11b+ 
macrophages into the genital tracts of infected mice also occurred, 
which could favor the differentiation of T regulatory cells, and 
thereby suppress immune responses against Gc (Imarai et al., 2008).
LIMITATIONS OF USING MICE TO STUDY GONOCOCCAL 
INFECTIONS
GENITAL TRACT pHYSIOLOGY
Several similarities and differences exist between the lower genital 
tracts of female mice and women. Similar factors include reduced 
O
2
 tension, the presence of glucose and lactate (Exley et al., 2007), 
and cytidine monophosphate N-acetylneuraminic acid (CMP-
NANA; Wu and Jerse, 2006) used to sialylate the Gc surface during 
infection. The average vaginal pH of estradiol-treated female mice is 
pH 6.6 (range 5.8–7.2; Muench et al., 2009). This pH is higher than 
human vaginal pH (average pH 3.5–4.5) but similar to human cer-
vical pH [proliferative stage, average 6.8 (5.5–8.0); secretory stage, 
average 6.1 (range 5.1–8.4)] (Singer, 1975), which is the primary 
site of infection in women. Hormonally driven changes in mucus 
viscosity, commensal flora (Braude, 1982), and histology (Corbeil 
et al., 1985) are similar to that which occurs in the human reproduc-
tive cycle. A major difference is the fact that there is no period of 
menstrual bleeding in mice that brings proteases, hemoglobin, and 
other serum factors into the reproductive tract. Fewer anaerobes 
colonize the murine genital tract compared to the normal micro-
biota of most women of reproductive age (Noguchi et al., 2003), 
but Gram-positive and Gram-negative facultatively anaerobic flora 
are present. The use of antibiotics to reduce potentially inhibitory 
commensal flora in the protocols we have described eliminates 
bacteria of the Enterobacteriaceae and Pseudomonas familes and 
most Gram-positive flora. Some mice remain colonized with Gram-
positive organisms, particularly when vancomycin is not used, and 
vaginal lactobacilli are frequently isolated (Jerse et al., 2002).
HOST RESTRICTIONS AND TRANSGENIC MICE
Colonization receptors
Gc expresses several ligands that bind to specific receptors to medi-
ate adherence or uptake by epithelial cells. At least three of these 
receptors are host-restricted. Colonization pili are expressed by the 
vast majority of human isolates (Kellogg et al., 1963); in contrast, 
murine vaginal isolates lose the piliated colony morphology over 
time (Jerse, 1999). Mice probably lack the pilus colonization recep-
tor, although its identity is unresolved. Human membrane cofactor 
protein (CD46) is hypothesized by some to serve as the neisserial 
pilus receptor (Kallstrom et al., 1997, 2001) and the demonstra-
tion that pilus-mediated interactions with CD46 trigger cellular 
responses through Src kinase-dependent phosphorylation (Lee 
et al., 2002; Weyand et al., 2009) suggests CD46 has an immu-
noregulatory role during infection. CD46+ transgenic mice support 
1985). Approximately 50% of infected BALB/c mice (range 30–80%) 
have a higher percentage of PMNs in stained vaginal smears on days 
4–5 compared to uninfected control mice (Jerse, 1999; Jerse et al., 
2002; Soler-Garcia and Jerse, 2007; Packiam et al., 2010), and signifi-
cantly more PMNs are detected within vaginal and cervical tissue 
from infected mice on days 2 and 5 post-inoculation. (Song et al., 
2008). Localized production of proinflammatory cytokines and 
chemokines IL-6, TNFα, KC, and MIP-2 is significantly increased 
on day 5 of infection, with MIP-2 expression positively correlating 
with PMN influx (Packiam et al., 2010; Figure 1B).
Mouse strain differences in susceptibility and host response 
have been documented. Like BALB/c mice, estradiol-treated CD1, 
SLC::ddY (Jerse, 1999), and C57BL/6 mice are susceptible to 
infection. Interestingly, Gc do not elicit an innate inflammatory 
response in C57BL/6 mice despite being colonized to similar levels 
as BALB/c mice (Packiam et al., 2010). C57BL/6 mice therefore 
appear to mimic asymptomatic infection and perhaps can be used 
to better define the pathways that lead to or suppress the inflam-
matory response to Gc. Known differences between C57BL/6 and 
BALB/c mice include the absence of phospholipase A2 in C57BL/6 
mice (Kennedy et al., 1995), which may play a role in generating 
lipid mediators (Kudo and Murakami, 2002) and inducing pro-
inflammatory cytokines and chemokines (Granata et al., 2005). 
Interestingly, estradiol-treated C3H/HeN mice are resistant to Gc 
(Packiam et al., 2010) and untreated C3H/HeN mice are also less 
susceptible to transient Gc colonization following intrauterine 
inoculation (Streeter and Corbeil, 1981). The natural resistance-
associated macrophage protein (Nramp1) is responsible for the 
resistance of C3H/HeN mice against pathogens that are highly 
adapted for life within macrophages (Forbes and Gros, 2001). The 
impact of Nramp1 on susceptibility to Gc infection is not known.
A significant advance in understanding the immune response to 
Gc was made recently by Mike Russell’s laboratory who showed Gc 
induces IL-17 responses and that secretion of IL-6, LIX, and MIP-2α 
is dependent on IL-17 receptor signaling. Importantly, inhibition of 
IL-17-induced responses in mice via antibody-mediated depletion 
of IL-17 or infection of IL-17 receptor knock-out mice resulted in 
increased recovery of bacteria and a significantly longer duration of 
infection compared to control mice (Feinen et al., 2010). The relevance 
of this finding to IL-17 responses in humans is supported by the recent 
report that levels of serum IL-17A and IL-23, which plays a role in 
the differentiation and proliferation of Th-17 cells, were elevated in 
patients with Gc urethritis or pharyngitis compared to healthy control 
subjects (Gagliardi et al., 2011). IL-17, along with IL-22, play a role in 
inducing antimicrobial peptides in epithelial cells (Kolls et al., 2008). 
Evidence that Gc induces IL-17 via endotoxin-mediated signaling 
through toll-like receptor 4 (TLR4; Feinen et al., 2010) may therefore 
provide a new angle for the design of preventive therapies.
There are many unresolved questions regarding the adaptive 
humoral response to Gc, which is not protective in humans and 
appears to be immunosuppressed. While there is some evidence 
of protective immunity in individuals with repeated exposure, 
humans can be reinfected with the same strain or serovar and anti-
body titers are not remarkable and decline over time (Sparling, 
1999; Russell and Hook, 2008). Mice also develop a transient and 
insignificant humoral response to infection and there was no 
evidence of a humoral memory response or reduced infection in 
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human cervical cells that do not express CEACAMs (Swanson et al., 
2001) and Opa− variants are more invasive than Opa+ variants in 
some systems (Song et al., 2000). The identification of bacterial 
ligands and receptors used during murine infection is handicapped 
by the lack of immortalized murine cervical or endometrial cell 
lines. Adherence and invasion pathway(s) exist for murine infec-
tion based on the visualization of Gc associated with genital tract 
cells (Jerse, 1999) and within mouse tissue (Song et al., 2008) and 
the detection of intracellular Gc in endometrial cells from murine 
uterine explant cultures (Imarai et al., 2008).
Iron-binding glycoproteins
The capacity of Gc to obtain iron from transferrin (Tf) and lacto-
ferrin (Lf) through specific receptors is also host-restricted (Lee 
and Schryvers, 1988). Expression of either the Tf or Lf receptor was 
critical for urethral infection of male subjects (Cornelissen et al., 
1998; Anderson et al., 2003), but the absence of these receptors or 
the hemoglobin receptor, which is not host-restricted (Stojiljkovic 
et al., 1996) does not confer a growth disadvantage in estradiol-
treated mice (Jerse et al., 2002). Usable iron sources in the female 
genital tract include siderophores produced by commensal flora 
(Mickelsen et al., 1982; Carson et al., 1999; Strange et al., 2010), 
hemin, and ferritin from dying epithelial cells, which are rapidly 
turned over during the course of the reproductive cycle (Schryvers 
and Stojiljkovic, 1999), and iron complexed to citric acid, oxalic 
acetate, pyrophosphate, nitrilotriacetate, or other metabolites 
(Mickelsen et al., 1982). Additionally, iron is likely to be more solu-
ble in the lower pH and reduced O
2
 tension of the female genital 
tract and thus more available to Gc. A transgenic hTf mouse strain 
was recently used as an improved model of N. meningitidis septice-
mia from which meningococci were recovered for a longer period 
and at a 100-fold higher concentration compared to wild type mice 
(Zarantonelli et al., 2007). The use of hTf transgenic mice may also 
significantly increase Gc genital tract colonization and perhaps sup-
port Gc infection of other body sites. However, the capacity of Gc to 
replicate in normal mice is direct evidence that non-host-restricted 
iron stores exist in the female lower genital tract.
Complement regulatory proteins
Gc that show inherently high levels of porin-mediated resistance 
to normal human serum bind the soluble regulatory proteins C4b-
binding protein (C4BP; Ram et al., 2001) and factor H (for strains 
of the P1A serotype; Ram et al., 1998) to down-regulate the clas-
sical and alternative pathways, respectively. Rice and colleagues 
showed that only human or chimpanzee fH and C4BP bind serum 
resistant strains, and the generation of hC4BP and/or hfH transgenic 
mice therefore holds promise for testing the importance of porin-
mediated serum resistance during female genital tract infection 
(Ngampasutadol et al., 2008b). Due to the role that complement 
activation plays in inducing cytokines and chemokines and the adap-
tive response (Dunkelberger and Song, 2010) such mice would also 
be a valuable resource for studying the host response to infection.
IgA1
Like many human-specific mucosal pathogens, Gc produces an 
IgA1 protease that cleaves only primate IgA1 (Qiu et al., 1996). How 
important IgA1 protease is for infection is not known. Russell and 
meningococcal dissemination to the brain following intranasal or 
intraperitoneal inoculation and induce higher levels of cytokines 
(Johansson et al., 2003, 2005). The impact of CD46 expression on 
Gc infection of mice has not been reported.
The human CR3 (hCR3) integrin is utilized by Gc to invade pri-
mary cervical cells via the binding of pili, LOS, and iC3b (Edwards 
et al., 2002). The hCR3 molecule has a high degree of similarity to 
murine CR3; however, it appears to be host-restricted based lack of 
staining with a hCR3-specific monoclonal antibody that blocks Gc 
invasion of human cells (unpublished data in collaboration with 
Drs. Jennifer Edwards and Michael Apicella). Additionally, Rice and 
colleagues recently showed human factor H (fH), which is host-
restricted (Ngampasutadol et al., 2008a), bridges the interaction 
between the gonococcus and CR3 (Agarwal et al., 2010). Therefore 
a transgenic mouse model that reproduces this invasion pathway 
may require the expression of both hCR3 and fH.
Other host-restricted receptors known to be used by Gc to invade 
epithelial cells include the human carcinoembryonic antigen cellular 
adherence molecules (CEACAMs) -1, -5 and -6 to which the phase 
variable opacity (Opa) proteins bind and CEACAM-3, through 
which Opa-mediated uptake by PMNs occurs in the absence of 
opsonization. Opa–CEACAM-1 binding causes immunosuppres-
sion of T cells and killing of B cells (Sadarangani et al., 2011). 
CEACAM transgenic mice are available (Eades-Perner et al., 1994; 
Bhattacharya-Chatterjee et al., 2008) and CEACAM-5 transgenic 
mice were recently used by Christof Hauck’s laboratory to dem-
onstrate a novel role for Opa–CEACAM interactions in preventing 
detachment of infected epithelial cells via enhancement of integrin-
mediated cell to cell adhesion and cellular adhesion to extracellular 
matix. CEACAM-5 transgenic mice had a higher colonization load 
than normal mice 1 day after inoculation. This finding supports 
the interesting hypothesis by this group that CEACAM-engaging 
bacteria subvert shedding from mucosal surfaces (Muenzner et al., 
2005, 2010). Additional studies with CEACAM transgenic mice 
are needed to demonstrate the Opa–CEACAM invasion pathway 
during female genital tract infection and test the role of Opa pro-
teins as immunosuppressive factors in vivo. Also, the importance 
of Opa–CEACAM-3 mediated uptake by PMNs relative to opsonic 
uptake during cervical infections, where complement is present 
in the absence of inflammation, is an interesting question that 
could potentially be addressed using complement depletion of 
CEACAM-3 transgenic mice.
Gc that express the lacto-N-neotetraose (LNT) species of LOS 
invade through the asialoglycoprotein receptor of primary urethral 
cells from men. This pathway is sex-specific (Edwards and Apicella, 
2004) and thus unlikely relevant to animal modeling of female 
infections. Other less characterized adhesins and invasins have been 
described including OmpA, which mediates invasion of immortal-
ized human endocervical and endometrial cells. Interestingly, an 
ompA mutant was attenuated for murine infection. OmpA was 
also required for uptake or survival within cultured murine mac-
rophages and whether the observed attenuation in vivo was due 
to a colonization versus survival advantage is not known (Serino 
et al., 2007). P1A strains undergo porin-mediated invasion through 
Gp96 and scavenger receptor SREC. This pathway is phosphate-
dependent and not restricted to human cells (van Putten et al., 
1998; Kuhlewein et al., 2006; Rechner et al., 2007). Gc also invades 
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generated new information that may be relevant to lower genital 
tract infection in women, particularly with regard to evasion of 
phagocytes, antimicrobial peptides, and commensal bacteria and 
adaptation to hormonally regulated factors (Figure 2B).
SIALYLTRANSFERASE bUT NOT ANTI-OxIDANT FACTORS pROTECT 
AGAINST pMNS
Gc is superbly adapted for evasion PMNs in which they survive 
and perhaps replicate (Casey et al., 1979; Simons et al., 2005; Criss 
et al., 2009). Examination of PMN killing mechanisms in the mouse 
system has the advantage of reproducing natural pathways of PMN 
recruitment and activation and physiologically relevant concen-
trations of iron, oxygen, and glucose needed to fuel the oxidative 
burst (Storz et al., 1990) and CMP-NANA, which when added to 
gonococcal LNT LOS via the action of α-2,3-sialylatransferase 
(Lst), increases resistance to complement-mediated uptake by 
PMNs (Smith et al., 1995; Gill et al., 1996). Additionally, PMNs 
from estradiol-treated mice produce a dose-dependent oxidative 
burst when exposed to Gc that is primarily intracellular (Soler-
Garcia and Jerse, 2007) as reported for human PMNs (Naids and 
Rest, 1991; Simons et al., 2005). Limitations include differences in 
the concentrations of myeloperoxidase and other granular enzymes 
colleagues found no evidence of IgA cleavage products in cervical 
fluid from women with gonorrhea (Hedges et al., 1998), and IgA2 
presumably can serve as a redundant protective factor. An IgA1 
protease mutant was not attenuated for urethral infection of naïve 
male volunteers (Johannsen et al., 1999), although its importance 
in previously infected subjects cannot be ruled out. Attenuation of 
an IgA1 protease mutant of Streptococcus pneumoniae in a mouse 
septicemia model (Polissi et al., 1998) suggests non-host-restricted 
roles exist for this class of enzymes. Gc IgA1 protease cleaves a 
phagosomal maturation protein to promote increased survival and 
transit through polarized epithelial cells (Lin et al., 1997; Hopper 
et al., 2000) and may modulate the host response based on the 
reported inhibition of apoptosis of immune cells and induction 
of proinflammatory cytokines by purified IgA1 protease in vitro 
(Lorenzen et al., 1999; Beck and Meyer, 2000). Whether these inter-
actions are host-restricted has not been reported.
pATHOGENESIS STUDIES
Gc encounters a variety of innate defenses in the female genital 
tract, some of which are illustrated in Figure 2A. The testing of 
bacterial mutants in factors that are hypothesized to promote Gc 
survival in vivo has confirmed predictions from in vitro studies and 
Figure 2 | gc interactions with innate defenses in the murine genital tract. 
Gc encounters a variety of innate defenses in the female genital tract including 
hydrophobic antimicrobial substances that bathe the mucosal surface, 
complement, and commensal flora (Boris and Barbes, 2000). Pathogen-induced 
activation of innate receptors on epithelial and immune cells causes secretion of 
antimicrobial peptides and proinflammatory cytokines and chemokines (Kolls 
et al., 2008), which recruit phagocytes to the infection site. PMNs can take up 
bacteria that are opsonized with complement deposition products. Phagocyte-
produced reactive oxygen species (ROS) kill bacteria by damaging DNA, protein, 
and other macromolecular structures (Storz et al., 1990). PMNs also kill 
microbes via the release of pre-formed enzymes and antimicrobial peptides and 
entrapment in neutrophil extracellular traps (NETs) where they are exposed to 
toxic molecules produced by both pathways (Kobayashi et al., 2005; 
Papayannopoulos and Zychlinsky, 2009). (A) Stained vaginal smear from a 
Gc-infected mouse reveals the presence of nucleated (NUC) and squamous 
(SQ) epithelial cells and PMNs with intracellular diplococci. Black arrows denote 
Gc and white arrows denote lactobacilli. Human strains of H2O2-producing 
lactobacilli can be added to this ecosystem as described (Muench et al., 2009). 
(B) Cartoon depicting the murine genital mucosa on the left and some of the 
bacterial factors that have been tested to measure their role in protection from 
host innate defenses on the right. Gc has many redundant anti-oxidant systems 
including Ccp (cytochrome c peroxidase), Kat (catalase), MsrA/B (a methionine 
sulfoxide reductase), and the MntA–MntB–MntC manganese transporter, which 
do not protect Gc from phagocyte-derived (Kat, Ccp, MntC; Wu et al., 2009), or 
Lactobacillus-derived (Kat, Ccp) ROS in vivo (Muench et al., 2009). Gc add host 
sialic acid to their LOS via the action of sialyltransferase. This modification 
reduces uptake of the bacteria by PMNs and increases survival in vivo (Wu and 
Jerse, 2006). Antimicrobial peptides (APs) are actively expelled from the cell via 
the MtrC–MtrD–MtrE efflux pump and inactivation of this system is highly 
attenuating for murine infection (Jerse et al., 2003).
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murine infection and inactivation of the lst gene confers a survival 
disadvantage in BALB/c mice. Decreased resistance to PMN killing 
is the most likely explanation for the observed attenuation based 
on the greater susceptibility of the lst mutant to opsonophagocytic 
uptake and killing by murine PMNs in vitro and significantly faster 
clearance of the lst mutant following intraperitoneal injection com-
pared to sialylated, wildtype bacteria (Wu and Jerse, 2006). LOS 
also increases resistance to complement-mediated bacteriolysis by 
enhancing the binding of fH to P1B porin (Madico et al., 2007). 
The importance of sialyltransferase in Gc survival is therefore likely 
underestimated in studies with normal mice due the host restriction 
for fH. While the host restriction for fH did not affect opsonophago-
cytosis at a functionally detectable level in our study, the lst mutant 
was equally attenuated in normal and C5-deficient mice (Wu and 
Jerse, 2006). These findings are consistent with the requirement for 
higher numbers of membrane attack complexes for bacteriolysis 
than opsonins for phagocytosis. Again, studies in fH transgenic mice 
could further illustrate the importance of sialyation in infection.
EvIDENCE OF COMpLEx INTERACTIONS bETwEEN GC AND 
LACTObACILLI
Epidemiological data show an increased risk for gonorrhea in 
women that lack vaginal lactobacilli, with some studies implicat-
ing H
2
O
2
-producing lactobacilli as a defense in particular (Antonio 
et al., 1999; Wiesenfeld et al., 2003) and others showing the same 
association regardless of the H
2
O
2
 production phenotype (Saigh 
et al., 1978; Hillier et al., 1992; Martin et al., 1999). It is not clear 
whether lactobacilli are directly responsible for the inverse correla-
tion between gonorrhea and vaginal lactobacilli because an absence 
of lactobacilli is associated with bacterial vaginosis in which an 
imbalance of other bacteria also occurs (Hillier et al., 1992). H
2
O
2
-
producing Lactobacillus sp. inhibit Gc in vitro (Saigh et al., 1978; St 
Amant et al., 2002), and Gc kat and ccp mutants are more suscepti-
ble than wild type Gc. However, surprisingly, there was no difference 
in the recovery of wild type, kat, or kat ccp mutant Gc from mice that 
were pre-colonized with H
2
O
2
-producing L. crispatus compared to 
mice that were not colonized with this human commensal (Muench 
et al., 2009). L. crispatus makes several factors that could enhance 
Gc growth or survival, one of which is lactate (Smith et al., 2007). 
As inactivation of the gonococcal lactate permease (lctP) gene was 
attenuating for murine infection (Exley et al., 2007), we hypoth-
esized that utilization of Lactobacillus-produced lactate might bal-
ance the detrimental effects caused by Lactobacillus-produced H
2
O
2
 
in vivo. However, a kat lctP Gc mutant also colonized mice with L. 
crispatus as well as mice without L. crispatus (Muench et al., 2009).
The murine infection data predict that vaginal H
2
O
2
-producing 
lactobacilli do protect against Gc, possibly because the O
2
 tension 
may not be sufficient for adequate H
2
O
2
 production. However, it 
is possible that H
2
O
2
 is more stable in the lower pH of the human 
vagina or the colonization density of L. crispatus in mice is not 
sufficiently high. A recent report that human cervical secretions 
block H
2
O
2
-mediated bactericidal activity however, also suggests 
Lactobacillus-derived H
2
O
2
 is not a formidable defense against STI 
pathogens (O’Hanlon et al., 2010). These studies do not rule out 
a role for other Lactobacillus factors in challenging N. gonorrhoeae 
(Spurbeck and Arvidson, 2010). Such factors may have also been 
produced by non-H
2
O
2
 producing murine lactobacilli in control 
in murine and human PMNs (Rausch and Moore, 1975), and the 
absence of Opa–CEACAM-mediated uptake by PMNs. Although it 
is possible that estradiol impairs PMN killing, we detect no differ-
ence in the killing capacity of PMNs from estradiol-treated versus 
untreated mice (Soler-Garcia and Jerse, 2007).
There is now much evidence that the oxidative burst of phago-
cytes does not challenge Gc, including studies with PMNs from 
humans with chronic granulomatous disease and the use of phar-
macological inhibitors of the respiratory burst (Rest et al., 1982; 
Criss et al., 2009). Infection studies in C57BL/6 mice that have 
a defective NADPH oxidase (Phox) provided in vivo evidence 
that phagocytic-derived ROS do not challenge Gc during genital 
tract infection (Wu and Jerse, 2006) with the caveat that C57BL/6 
mice do not produce a signficant PMN response to Gc infection 
(Packiam et al., 2010). Whether this host defense is more potent 
in body sites where oxygen levels are higher such as the pharynx, 
is not known, but seems unlikely based on PMN killing assays 
performed under anaerobic versus aerobic conditions (Casey et al., 
1986; Frangipane and Rest, 1992).
Perhaps a bigger question is how Gc evades phagocyte-derived 
ROS. Gc is equipped with a battery of factors that protect it from 
in vitro exposure to H
2
O
2
 and inducers of intracellular and extra-
ceullar ROS, including the detoxifying enzymes catalase (Kat) and 
cytochrome C peroxidase (Ccp), non-enzymatic quenching of O2
− 
by Mn2+, which is taken up by the manganese transporter MntABC, 
methionine sulfoxide reductase (MsrA/B), which repairs oxidatively 
damaged proteins, a thiol-disulfide oxidoreductase (Sco), azurin, bac-
terioferritin and novel peroxidase-induced genes of unknown func-
tion (Seib et al., 2006). This abundance of anti-oxidant mechanisms is 
impressive, yet there if no evidence that these factors protect Gc from 
the vigorous PMN response encountered in vivo. For example, a kat 
mutant and kat ccp and kat sco mutants of strain 1291 were not more 
susceptible to killing by human PMNs (Seib et al., 2005). Similarly, 
single, double, and triple mutants in the kat, ccp, msrAB, and mntC 
genes in strain MS11 were not more susceptibile to killing by murine 
PMNs. These mutants were also not attenuated during infection of 
normal BALB/c mice or Phox-deficient and Phox-sufficient C57BL/6 
mice (Wu et al., 2009). Further genetic stripping of the factors known 
to protect Gc from exposure to H
2
O
2
 or inducers of ROS may debilitate 
Gc against O
2
-dependent PMN killing. The answer may, however, 
reside in novel mechanisms that do not involve direct protection from 
ROS (Lorenzen et al., 2000; Criss and Seifert, 2008; Criss et al., 2009).
Possible new functions for MsrA and MntC were revealed using 
murine infection. The msrA mutant showed delayed attenutation 
in vivo in BALB/c mice and because macrophages appear later than 
PMNs during infection of BALB/c mice (Song et al., 2008) reduced 
recovery of msrA mutant may be due to increased sensitivity to mac-
rophage killing as described for other bacteria (St John et al., 2001; 
Douglas et al., 2004). Additionally, inactivation of mntC resulted in 
an attenutated phenotype in normal BALB/c and Phox-deficient 
and Phox-sufficient C57BL/6 mice. MntC-deficient Gc may be 
more susceptible to ROS produced by epithelial cells. Inactivation 
of mntC may also reduce biofilms, which may be important in 
stabilizing colonization (Lim et al., 2008).
In contrast to the anti-oxidant factors tested above, Lst plays a 
detectable role in defending Gc from PMN killing in vitro and in 
the mouse model. Sialylation of Gc occurs within the first day of 
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in the types of innate effectors that select for mtrR locus mutations. 
Alternatively, mtrR locus mutants frequently carry more than one 
antibiotic resistance mutation, which may confer an overall fitness 
cost (Komp Lindgren et al., 2005).
ADApTATION TO HORMONALLY REGULATED FACTORS THROUGH opA 
GENE pHASE vARIATION
The neisserial Opa proteins are a family of phase variable outer 
membrane proteins that are encoded by 10–12 unlinked genes 
(Simms and Jerse, 2005). Selection for Opa expression during ure-
thral infection occurs in naturally (James and Swanson, 1978) and 
experimentally infected male volunteers (Swanson et al., 1988; Jerse 
et al., 1994). Selection for Opa variants in the female genital tract 
appears more complex, with predominantly opaque (Opa+) colo-
nies isolated during the proliferative stage of the menstrual cycle 
and transparent (Opa−) colonies isolated during or shortly after 
menses. Based on this intriguing observation, James and Swanson 
(1978) hypothesized that subpopulations of bacteria are better 
adapted for different stages of the reproductive cycle. This hypoth-
esis is consistent with reported higher rates of positive cultures 
from women with gonorrhea during the proliferative stage than 
the middle secretory stage (Koch, 1947; Johnson et al., 1969; James 
and Swanson, 1978; McCormack and Reynolds, 1982; Figure 3A).
Interestingly, Opa+ variants are isolated from BALB/c mice 
in a cyclical recovery pattern that consists of early (Opa+), mid 
(Opa−) and late (Opa+) phases. Consistent with subpopulations 
of bacteria being cleared or having an advantage, fluctuations 
in the predominant Opa phenotype recovered are paralleled by 
changes in the total number of Gc recovered (Simms and Jerse, 
2006; Figure 3B). A cyclical recovery pattern also occurs during 
short-term colonization of mice that are not treated with estra-
diol. The importance of Opa proteins during the early and late 
phases was confirmed by the demonstration that an Opa-deficient 
mutant colonized mice less well than the mutant expressing one 
functional opa allele during the first day of infection, and unlike 
the Opa-deficient strain, the Opa+ strain was recovered following 
the mid-phase (Cole et al., 2010). A link between the reproduc-
tive cycle and the cyclical recovery pattern was revealed by studies 
with ovariectomized mice, which select for Opa+ variants early in 
infection and maintain this selection over time. Also, unlike intact 
(normal) mice, fluctuations in the number of Gc recovered from 
ovariectomized mice were not observed (Cole et al., 2010). The 
selective forces responsible for the cyclical changes in Opa phe-
notype in normal mice must be due to a CEACAM-independent 
Opa function. Complement was shown to preferentially kill Opa+ 
variants of strain MS11 (Bos et al., 1997) and complement levels 
in the female human and murine genital tracts are hormonally 
regulated (Hasty et al., 1994; Li et al., 2002). However, experiments 
with complement-depleted mice did not support complement as 
the selective factor (Cole et al., 2010).
The factors that select for Opa+ variants during human infections 
are also not known. In women, CEACAM-mediated adherence to 
and invasion of cervical cells may select for Opa-expressing variants 
during infection, as may increased attachment of epithelial cells 
with adherent bacteria (Muenzner et al., 2005, 2010) as discussed. 
Based on data from BALB/c mice, we hypothesize that CEACAM-
independent factors also exist. CEACAMs were not detected on 
mice in the mouse study discussed above. Nonetheless, interest-
ing observations have been made while working with the mouse 
model in our laboratory that suggest Gc has evolved mechanisms to 
coexist with these commensals. For example, L. murinus, a mouse 
Lactobacillus sp., supports growth of Gc on solid agar (Jerse et al., 
2002) as do H
2
O
2
-producing human Lactobacillus strains if catalase 
is added, and mice with L. murinus usually have a very high Gc 
colonization load (A. E. Jerse, unpublished observation).
THE MTRC–MTRD–MTRE ACTIvE EFFLUx pUMp pLAYS AN IMpORTANT 
ROLE IN EvASION OF HOST DEFENSES
Gc produces several active efflux pump systems that expel anti-
microbial substances from the periplasm. Host-derived substrates 
expelled by the MtrC–MtrD–MtrE efflux pump system include 
human cathelicidin LL37, the mouse homolog cathelicidin-
related antimicrobial peptide (CRAMP), progesterone, and fatty 
acids (Shafer et al., 2001; Jerse et al., 2003; Warner et al., 2008). 
MtrCDE-deficient mutants are the most attenuated of all mutants 
tested thus far in the mouse model, which is consistent with a role 
for this efflux system in protecting against host defenses (Jerse 
et al., 2003). Inactivation of MtrR and MtrA, which negatively 
and positively regulate mtrCDE expression, respectively causes a 
phenotype in mice that is consistent with the importance of the 
MtrC–MtrD–MtrE efflux pump in infection (Warner et al., 2007). 
In contrast, the FarA–FarB–MtrE efflux pump system does not 
have a detectable role in murine infection (Jerse et al., 2003). This 
system primarily protects Gc from long chain fecal lipids, and thus 
may be more important during rectal infections (Lee and Shafer, 
1999). Infection studies in mice that are deficient in CRAMP (Nizet 
et al., 2001) may facilitate further investigation of the role of the 
MtrC–MtrD–MtrE pump in infection; however, the presence of 
more than one pump substrate may complicate definitive identifi-
cation of host factors that challenge MtrCDE-deficient Gc in vivo. 
mtrE mutants are also more sensitive to bactericidal/permeability-
increasing (BPI) protein (A. A. Begum and A. E. Jerse, unpublished 
data), which is a lipid A-binding protein that is present in both the 
human and murine genital tracts (Canny et al., 2006; Eckert et al., 
2006). Also, increased susceptibility of MtrCDE-deficient Gc to 
progesterone in vitro and the faster clearance of MtrCDE-deficient 
Gc from normal mice versus ovariectomized mice suggests proges-
terone or progesterone-regulated factors challenge these mutants 
during infection.
Derepression of the mtrCDE operon through a single base pair 
deletion in the mtrR promoter region or point mutations in the 
MtrR structural gene is a mechanism by which Gc strains become 
resistant to macrolide antibiotics and high levels of penicillin 
(Shafer et al., 2001). Antibiotic resistance mutations often confer 
reduced fitness in vitro due to the effect these mutations have on 
growth. An exception to this paradigm are mtrR locus mutations 
that confer increased fitness in the mouse model. Commonly iso-
lated mtrR locus mutations confer different levels mtrCDE dere-
pression, which is mirrored by different levels of fitness advantage in 
vivo (Warner et al., 2008). One might predict that the percentage of 
mtrR locus mutants would be higher among clinical isolates should 
the observed fitness benefit in mice hold true for human infection. 
It may be that the mouse data are not predictive of events during 
human infection or there are sex-based or anatomical differences 
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sion (Cohen et al., 1997). Alarmingly, the reliance on antibiotic 
treatment as a control measure is seriously threatened by the rapid 
emergence of antibiotic-resistant strains (Tapsall et al., 2005). The 
need for an animal model to facilitate pre-clinical testing of prod-
ucts against gonorrhea was reflected by the numerous academic 
and industrial collaborators who approached our laboratory upon 
the first publication of the mouse model. Continued research in 
this area is critical. Here we briefly describe our experience with 
testing vaccines and vaginal microbicides in the mouse model with 
an emphasis on practical considerations and challenges for product 
development.
Vaccine development
Successful development of a gonorrhea vaccine faces many chal-
lenges as recently reviewed (Zhu et al., 2011). The availability of an 
animal model for systematic testing of different antigens, immu-
nization strategies, and defining correlates of protection should 
facilitate vaccine development as should growing information on 
protective immunological pathways in mice and humans (Imarai 
et al., 2008; Feinen et al., 2010; Gagliardi et al., 2011). An OMV-
based vaccine demonstrated protection against strain MS11 (Plante 
et al., 2000) but was not successful in subsequent studies or with 
other strains (Zhu et al., 2011). As of yet, vaccine-induced protec-
tion of mice with other antigens has not been reported, although 
data we have obtained thus far are useful for evaluating the effec-
tiveness of different immunization  strategies in inducing local and 
systemic immune responses. A practical obstacle for vaccine studies 
primary urethral cells from men (Edwards and Apicella, 2004) and 
therefore, the selection of Opa+ Gc during natural or experimental 
urethral infection of men may also be due to another factor(s).
The reason for periods of reduced recovery of Gc from female 
mice and women is also not understood. In women, the capacity of 
Gc to invade and survive within cervical cells via the host-restricted 
CR3 pathway is affected by reproductive hormones and therefore, 
the presence of Gc within intracellular niches may contribute to 
cyclical culture rates from women (Edwards, 2010). Hormonally 
driven changes in metalloprotease and cathepsin expression, which 
function to remodel tissue (Afonso et al., 1997; Jokimaa et al., 
2001), could also open avenues for invasion into tissue in mice 
or women as described for other pathogens (Azghani et al., 2000; 
Katz et al., 2000) or alter the host response as demonstrated for 
chlamydial infection using matrix metalloprotease nine knock-out 
mice (Imtiaz et al., 2007). Up-regulation of anti-Gc effectors during 
the luteal phase of the cycle may also contribute to selection patterns 
via hormonal regulation of TLRs (Yao et al., 2007).
FUTURE DIRECTIONS
pRODUCT DEvELOpMENT
Safe and effective therapeutic and prophylactic products against Gc 
are greatly needed to reduce the incidence of gonorrhea and protect 
women’s reproductive health. Infertility treatment is a significant 
and hidden cost of ascended infections and ectopic pregnancy 
causes 4.1% of maternal-related deaths in industrialized countries 
(Khan et al., 2006). Gonorrhea is also a cofactor for HIV transmis-
Figure 3 | The reproductive cycle influences gc infection of women and 
mice. (A) Culture rates from women with gonorrhea and the opacity phenotype 
of cervical isolates from infected women with respect to stages of the 
menstrual cycle (Koch, 1947; Johnson et al., 1969; James and Swanson, 1978; 
McCormack and Reynolds, 1982). In one study, women with gonorrhea were 
hospitalized without treatment and in four of four women, positive cultures were 
followed by five to six consecutive negative cultures during the secretory phase; 
cultures became positive again at menses (Koch, 1947). Gonococcal PID and 
disseminated gonococcal infection most frequently occur at or shortly after 
menses (Holmes et al., 1971) and Gc from fallopian tubes from women with 
salpingitis were reported to be Opa− (Draper et al., 1980). (B) Cartoon depicting 
the cyclical recovery pattern seen in intact mice following inoculation with 
mostly Opa− variants of strain FA1090. Within a day after inoculation with mostly 
Opa− Gc, Opa+ variants predominate (early phase). This phase is followed by a 
period in which mostly Opa− variants are isolated (mid-phase) and then a second 
Opa+ phase (late phase). A high percentage of isolates express multiple Opa 
proteins in the late phase. In mice that remain infected for more than 8 days, a 
second mid-phase is observed. The rise and fall of the Opa+ population 
corresponds to fluctuations in the total number of Gc recovered. This pattern is 
not seen in Ov− mice. Hostile factors may reduce colonization during the 
mid-phase or perhaps Opa+ variants are less accessible for culture due to tissue 
invasion (Simms and Jerse, 2006; Cole et al., 2010).
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An important charactersitic of STIs is the frequency by which more 
than one pathogen is present. The availability of well character-
ized models of gonorrhea (Song et al., 2008), chlamydia (Darville 
et al., 2003), and M. genitalium (McGowin et al., 2009) infection 
affords the opportunity to develop coinfection models for these 
three pathogens, which are major causes of PID. As many as 70% of 
individuals with gonorrhea have chlamydia (Miller et al., 2004) and 
we recently developed a gonorrhea chlamydia coinfection model 
for use as a research tool (Vonck et al., 2011). Significantly more 
vaginal PMNs were detected in coinfected mice compared to mice 
infected with either pathogen alone. This result is consistent with 
the reported higher levels of symptoms in individuals coinfected 
with Gc and C. trachomatis (Nsuami et al., 2004; Rosenvinge and 
Lau, 2009). Interestingly, higher numbers of Gc were recovered 
from coinfected mice compared to mice infected with Gc alone 
(Vonck et al., 2011). Continued use of the gonorrhea chlamydia 
coinfection model combined with human-based systems should 
illuminate the basis for these observations. The development of 
dually active therapeutic agents should also be accelerated by this 
model. Such agents are needed to simplify treatment regimens and 
potentially reduce the costs associated with therapy.
SUMMARY
The development of the estradiol-treated mouse model of Gc infec-
tion has expanded the research tools available for studying Gc genital 
tract infections. Researchers can now experimentally manipulate 
the host response and utilize mice that are genetically defective in 
immunological pathways and effector molecules to inform our 
understanding of the host response against gonorrhea, as has ben-
efitted the study of many other infectious diseases. The growing 
availability of transgenic mice should improve the relevance of mice 
as surrogate hosts for Gc and provide an opportunity to test the bio-
logical significance of host-restricted bacterial–host cell interactions 
observed in vitro. The mouse model is also a useful system for study-
ing hormonal influences on bacterial–host cell interactions, which 
is an exciting but understudied area. Finally, the mouse model has 
accelerated product testing, which is greatly needed for gonorrhea, 
and can be adapted to develop STI coinfection models.
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in the estradiol-treated mouse model is the need to immunize more 
mice than are actually challenged since only diestrus or anestrus 
stage mice can be used in the challenge phase of the experiment. 
Ovariectomized mice can be used to circumvent this problem 
since they do not need to be staged prior to estradiol treatment. 
Ovariectomized mice are more expensive, however, and we specu-
late that their innate responses may be compromised based on the 
absence of the cyclical recovery pattern in ovariectomized mice 
as discussed (Cole et al., 2010). Certain host restrictions should 
especially be considered when testing vaccines for humans. IgA1 
protease and restrictions in the complement cascade may most 
significantly challenge the power of murine infection to predict 
vaccine efficiacy, particularly against serum resistant strains. The 
development of hC4BP and fH transgenic mice should therefore 
be a useful tool for vaccine testing (Ngampasutadol et al., 2008b). 
Passive delivery of purified fH or hC4BP could also be used as was 
recently shown to improve experimental infection of rats by N. 
meningitidis (Granoff et al., 2009).
Vaginal microbicides
The development of topically applied products for reducing 
the risk of STIs in women has been a public health priority in 
recent years. Topical agents that have been tested against Gc in 
the estradiol-treated mouse model include porphyrin binding 
proteins (Bozja et al., 2004), formulated natural, and synthetic sul-
fated and sulfonated polymers [CarraGuard™, Ushercell, T-PSS, 
PRO 2000™], acid-buffering agents [ACIDFORM, BufferGel™], 
and cellulose acetate phthalate (CAP; Spencer et al., 2004). 
With the exception of Carraguard, there was good correlation 
between the in vitro activity of each agent and effectiveness in 
vivo. Interestingly, CarraGuard prevented infection of mice but 
did not inhibit Gc in vitro (Spencer et al., 2004). This finding 
underscores the importance of testing products in an animal 
model system. Several of these products have since undergone 
safety and acceptiblity testing in humans (Carraguard, 2010; von 
Mollendorf et al., 2010).
Many challenges face the assessment of vaginal microbicide 
effectiveness in humans (Ramjee et al., 2010), but animal mod-
eling can continue to play useful role in the development of these 
products for screening novel compounds and expanding testing 
protocols to include the assessment of repeated application of 
agents, which can affect susceptiblity (Cone et al., 2006). A limita-
tion of the gonorrhea mouse model, like most STI models, is that 
it is not a transmission model and the bacterial suspension used to 
inoculate mice does not simulate the bodily fluids that transmit the 
microbe in terms of pH, biochemical make-up, and the presence 
of immune effectors and inhibitors of host defenses.
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